Literature DB >> 25119075

[Drug prescriptions of patients treated in a geriatric outpatient ward of a university hospital: a descriptive cross-sectional study].

Vanessa da Silva Cuentro1, Marcieni Ataide de Andrade1, Letícia Farias Gerlack2, Angelo José Gonçalves Bós3, Marcos Valério Santos da Silva1, Alex Ferreira de Oliveira4.   

Abstract

The scope of this study was to evaluate drug prescriptions for elderly patients in the geriatric outpatient ward of a hospital. A cross-sectional descriptive study was conducted in a university hospital, with the application of a questionnaire. Patients aged >60 years were interviewed about their drug prescriptions and a total of 208 patients were interviewed. The average number of drugs used per person was 3.8 and the drugs most used were for the cardiovascular system (37%). 406 potential interactions were identified in 140 patients (67.3%), and duplicate therapy was found in two prescriptions. The potentially inappropriate drug most used for the elderly was nifedipine (2.4%). Data from this study support the relevance of the issue of drug use among the elderly, thus reinforcing the importance of the evaluation of the process of the prescription of drugs for this population.

Entities:  

Mesh:

Year:  2014        PMID: 25119075     DOI: 10.1590/1413-81232014198.09962013

Source DB:  PubMed          Journal:  Cien Saude Colet        ISSN: 1413-8123


  2 in total

1.  Patient Factors Associated with Pharmaceutical Interventions for Inpatients at a Brazilian Teaching Hospital.

Authors:  Debora Bernardes Francisco; Karine Dal Paz; Thiago Vinicius Nadaleto Didone
Journal:  Can J Hosp Pharm       Date:  2021-07-01

2.  Potentially inappropriate medications for the elderly: Incidence and impact on mortality in a cohort ten-year follow-up.

Authors:  Natacha Christina de Araújo; Erika Aparecida Silveira; Brenda Godoi Mota; João Paulo Neves Mota; Ana Elisa Bauer de Camargo Silva; Rafael Alves Guimarães; Valéria Pagotto
Journal:  PLoS One       Date:  2020-10-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.